Showing 741 - 760 results of 36,815 for search '(( 50 ((((na decrease) OR (a decrease))) OR (nn decrease)) ) OR ( 12 mean decrease ))', query time: 0.97s Refine Results
  1. 741
  2. 742
  3. 743
  4. 744
  5. 745
  6. 746
  7. 747
  8. 748
  9. 749

    Effects of siRNA TMPRSS2-ERG on ERG protein expression and cell viability. by Giorgia Urbinati (554921)

    Published 2015
    “…<p>VCaP cells were transfected for 24h, 48h and 72h with 50 nM of siRNAs TMPRSS2-ERG III (1, 2, 3), siRNAs TMPRSS2-ERG IV (1, 2), siRNA against ERG wild type or siRNA Control. …”
  10. 750
  11. 751

    Antineoplastic Effects of siRNA against TMPRSS2-ERG Junction Oncogene in Prostate Cancer by Giorgia Urbinati (554921)

    Published 2015
    “…The siRNA against TMPRSS2-ERG fusion variant IV showed the highest anti-proliferative effects: Significantly decreased cell viability, increased cleaved caspase-3 and inhibited a cluster of anti-apoptotic proteins. …”
  12. 752
  13. 753

    Low concentrations of siRNA TMPRSS2-ERG III and IV impair TMPRSS2-ERG oncogene and oncoprotein levels but not cell viability. by Giorgia Urbinati (554921)

    Published 2015
    “…<p>VCaP cells were transfected for 72h from 2.5 nM to 50 nM with siRNA TMPRSS2-ERG III, siRNA TMPRSS2-ERG IV or siRNA Control. …”
  14. 754

    List of mRNAs that are differentially expressed in both the RNAPII ChIP-seq and RNA-seq datasets, mRNAs with decreased expression in both lists, and mRNAs that have decreased expre... by Katherine I. Farley-Barnes (9258036)

    Published 2020
    “…<p>List of mRNAs that are differentially expressed in both the RNAPII ChIP-seq and RNA-seq datasets, mRNAs with decreased expression in both lists, and mRNAs that have decreased expression in both lists and are also nucleolar in at least 1 database [<a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1008967#pgen.1008967.ref050" target="_blank">50</a>–<a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1008967#pgen.1008967.ref052" target="_blank">52</a>].…”
  15. 755

    Flowchart of patients. by Seydou Goro (17847203)

    Published 2024
    “…</p><p>Results</p><p>Ninety-five percent (n = 152,235) of the 160,909 people operated on for colorectal cancer were included in our study. The mean age of patients was 70.4 ±12.2 years old, and female were more represented (55%). …”
  16. 756
  17. 757
  18. 758
  19. 759

    Decrease in proliferation after ENU-exposure as decrease in BrdU immunostaining. by Vivian Capilla-Gonzalez (336046)

    Published 2013
    “…<p>Micrograph of the BrdU+ cells immunolabeled with DAB showed a decrease in the proliferation in the SVZ (B) and DG (D) of treated animals, compared with control group (A and C, respectively). …”
  20. 760

    Mean changes in initial inocula at the end of dosing intervals: Decrease in log<sub>10</sub> cfu/ml initial inocula in antibiotic simulations at 12h (solid grey) and 24h (solid black); or increase in log<sub>10</sub> cfu/ml initial inocula in antibiotic-free simulations at 12h (grey diagonal stripes) and at 24h (black diagonal stripes). by David Sevillano (308903)

    Published 2013
    “…<p>Mean changes in initial inocula at the end of dosing intervals: Decrease in log<sub>10</sub> cfu/ml initial inocula in antibiotic simulations at 12h (solid grey) and 24h (solid black); or increase in log<sub>10</sub> cfu/ml initial inocula in antibiotic-free simulations at 12h (grey diagonal stripes) and at 24h (black diagonal stripes).…”